Central Hyperthermia Treated with Cabergoline: A Case Report

Adel Mohammed Taha (1) , Ebrahim Khair Al-Yousef (2) , Duaa Salem Jawhar (3)
(1) Department of Anaesthesia and Critical Care, Saqr Hospital, Emirates Health Services, Ras Al Khaimah, United Arab Emirates , Saudi Arabia
(2) Department of Surgery (Neurosurgery), Saqr Hospital, Emirates Health Services, Ras Al Khaimah, United Arab Emirates , Saudi Arabia
(3) Department of Pharmacy (Clinical Pharmacy), Saqr Hospital, Emirates Health Services, Ras Al Khaimah, United Arab Emirates , Saudi Arabia

Abstract

A 36-year-old male with acute traumatic spinal cord injury (ATSCI) was diagnosed with central hyperthermia after a worksite injury.After the management of infection with antibiotics guided by culture & sensitivity results and presence of persistent fever (> 40°C), tablet Cabergoline was prescribed (0.5mg every week) in Hospital Day 23. Improvement in the temperature chart was noticed from Hospital Day 29 and persisted. Tablet Cabergoline may have a role in the management of Central hyperthermia.

Full text article

Generated from XML file

Authors

Adel Mohammed Taha
dr.duaasalem@gmail.com (Primary Contact)
Ebrahim Khair Al-Yousef
Duaa Salem Jawhar
Taha, A. M. ., Al-Yousef, E. K. ., & Jawhar, D. S. . (2022). Central Hyperthermia Treated with Cabergoline: A Case Report. Journal of Current Medical Research and Opinion, 5(11), 1486–1489. https://doi.org/10.52845/CMRO/2022/5-11-4
Copyright and license info is not available

Article Details